Skip to content
OpenCapital
Get started

Intellia Therapeutics NTLA Invested capital

Discontinued — last reported Q1 '26

Invested capital at other companies

Travel + Leisure logo
Travel + LeisureTNL
18.8%+0.1pp
Belden logo
BeldenBDC
12.2%+0.5pp
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
3.4%+1.8pp
Liberty Broadband Corporation logo
Liberty Broadband CorporationLBRDK
-0.3%-0.1pp
Archer Aviation logo
Archer AviationACHR
-129.7%-62.3pp
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
17.5%+14.2pp

Other financials

Income statement

See full
Revenue$15.0M-9.5%
Operating income-$100.5M+16.8%
Net income-$96.2M+15.8%
EPS (diluted)-$0.81+26.4%

Balance sheet

See full
Cash & equivalents$134.7M+6.2%
Total debt$80.5M-32.5%
Total equity$620.9M-20.4%
Total assets$758.8M-23.1%

Cash flow

See full
Operating cash flow-$117.3M+21.2%
CapEx$79.0K-89.3%
Free cash flow-$117.4M+21.5%

Valuation

See full
Market cap$2.17B+106%

Profitability

See full
Operating margin-636.6%-202pp
Net margin-597%-194pp
FCF margin-550.2%-140pp

Returns & leverage

See full
Return on equity-56.3%-1.5pp
Debt / equity0.1×0.0×
Current ratio6.1×+1.2×

Where this comes from

Calculated from Intellia Therapeutics’s reported figures.

$80.5Mtotal debt+$620.9Mtotal stockholders equity−$134.7Mcash and equivalents=$566.73M

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Intellia Therapeutics's invested capital?
Intellia Therapeutics (NTLA) reported invested capital of $566.73M in Q1 2026.
How has Intellia Therapeutics's invested capital changed year-over-year?
Intellia Therapeutics's invested capital decreased by 26.6% year-over-year, from $772.29M to $566.73M.
What is the long-term trend for Intellia Therapeutics's invested capital?
Over 5 years (2020 to 2025), Intellia Therapeutics's invested capital has grown at a 8.4% compound annual growth rate (CAGR), from $406.36M to $609.26M.
What does invested capital mean?
Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).